Global Acute Kidney Injury Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • Report Code : AMP716910
  • Published : Jul, 2019
  • Category : Healthcare & Pharma
  • Publisher : Global Info Research
  • Pages : 101
Overview

Ample Market Research published a report, titled, "Global Acute Kidney Injury Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024". The study provides insights on the present scenario as well as the growth prospects of the “Global Acute Kidney Injury Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024”. It presents the qualitative and quantitative analysis of the industry by analyzing the current trends, market growth drivers, restraints, opportunities, and various marketing strategies adopted by the players.

Players/Companies included
  • Angion Biomedica Corp
  • LG Chem
  • Baxter International
  • Inc.
  • Quark Pharmaceuticals
  • Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • B. Braun Melsungen AG
  • Asahi Kasei Medical Co.
  • Ltd.

  • Scope of the Report:

    The global Acute Kidney Injury Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

    The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

    North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Acute Kidney Injury Treatment.

    Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

    This report studies the Acute Kidney Injury Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Acute Kidney Injury Treatment market by product type and applications/end industries.


    Market Segment by Companies, this report covers

    Angion Biomedica Corp

    LG Chem

    Baxter International, Inc.

    Quark Pharmaceuticals, Inc.

    Fresenius Medical Care AG & Co. KGaA

    B. Braun Melsungen AG

    Asahi Kasei Medical Co., Ltd.


    Market Segment by Regions, regional analysis covers

    North America (United States, Canada and Mexico)

    Europe (Germany, France, UK, Russia and Italy)

    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

    South America (Brazil, Argentina, Colombia)

    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)


    Market Segment by Type, covers

    Prerenal Acute Kidney Injury

    Postrenal Acute Kidney Injury

    Intrinsic Renal Acute Kidney Injury


    Market Segment by Applications, can be divided into

    Hospitals

    Ambulatory Surgical Centers

    Others

     

  • Table of Contents

    1 Acute Kidney Injury Treatment Market Overview

    1.1 Product Overview and Scope of Acute Kidney Injury Treatment

    1.2 Classification of Acute Kidney Injury Treatment by Types

    1.2.1 Global Acute Kidney Injury Treatment Revenue Comparison by Types (2019-2024)

    1.2.2 Global Acute Kidney Injury Treatment Revenue Market Share by Types in 2018

    1.2.3 Prerenal Acute Kidney Injury

    1.2.4 Postrenal Acute Kidney Injury

    1.2.5 Intrinsic Renal Acute Kidney Injury

    1.3 Global Acute Kidney Injury Treatment Market by Application

    1.3.1 Global Acute Kidney Injury Treatment Market Size and Market Share Comparison by Applications (2014-2024)

    1.3.2 Hospitals

    1.3.3 Ambulatory Surgical Centers

    1.3.4 Others

    1.4 Global Acute Kidney Injury Treatment Market by Regions

    1.4.1 Global Acute Kidney Injury Treatment Market Size (Million USD) Comparison by Regions (2014-2024)

    1.4.1 North America (USA, Canada and Mexico) Acute Kidney Injury Treatment Status and Prospect (2014-2024)

    1.4.2 Europe (Germany, France, UK, Russia and Italy) Acute Kidney Injury Treatment Status and Prospect (2014-2024)

    1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Kidney Injury Treatment Status and Prospect (2014-2024)

    1.4.4 South America (Brazil, Argentina, Colombia) Acute Kidney Injury Treatment Status and Prospect (2014-2024)

    1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Kidney Injury Treatment Status and Prospect (2014-2024)

    1.5 Global Market Size of Acute Kidney Injury Treatment (2014-2024)

    2 Company Profiles

    2.1 Angion Biomedica Corp

    2.1.1 Business Overview

    2.1.2 Acute Kidney Injury Treatment Type and Applications

    2.1.2.1 Product A

    2.1.2.2 Product B

    2.1.3 Angion Biomedica Corp Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.2 LG Chem

    2.2.1 Business Overview

    2.2.2 Acute Kidney Injury Treatment Type and Applications

    2.2.2.1 Product A

    2.2.2.2 Product B

    2.2.3 LG Chem Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.3 Baxter International, Inc.

    2.3.1 Business Overview

    2.3.2 Acute Kidney Injury Treatment Type and Applications

    2.3.2.1 Product A

    2.3.2.2 Product B

    2.3.3 Baxter International, Inc. Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.4 Quark Pharmaceuticals, Inc.

    2.4.1 Business Overview

    2.4.2 Acute Kidney Injury Treatment Type and Applications

    2.4.2.1 Product A

    2.4.2.2 Product B

    2.4.3 Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.5 Fresenius Medical Care AG & Co. KGaA

    2.5.1 Business Overview

    2.5.2 Acute Kidney Injury Treatment Type and Applications

    2.5.2.1 Product A

    2.5.2.2 Product B

    2.5.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.6 B. Braun Melsungen AG

    2.6.1 Business Overview

    2.6.2 Acute Kidney Injury Treatment Type and Applications

    2.6.2.1 Product A

    2.6.2.2 Product B

    2.6.3 B. Braun Melsungen AG Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.7 Asahi Kasei Medical Co., Ltd.

    2.7.1 Business Overview

    2.7.2 Acute Kidney Injury Treatment Type and Applications

    2.7.2.1 Product A

    2.7.2.2 Product B

    2.7.3 Asahi Kasei Medical Co., Ltd. Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Acute Kidney Injury Treatment Market Competition, by Players

    3.1 Global Acute Kidney Injury Treatment Revenue and Share by Players (2014-2019)

    3.2 Market Concentration Rate

    3.2.1 Top 5 Acute Kidney Injury Treatment Players Market Share

    3.2.2 Top 10 Acute Kidney Injury Treatment Players Market Share

    3.3 Market Competition Trend

    4 Global Acute Kidney Injury Treatment Market Size by Regions

    4.1 Global Acute Kidney Injury Treatment Revenue and Market Share by Regions

    4.2 North America Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    4.3 Europe Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    4.4 Asia-Pacific Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    4.5 South America Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    4.6 Middle East and Africa Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    5 North America Acute Kidney Injury Treatment Revenue by Countries

    5.1 North America Acute Kidney Injury Treatment Revenue by Countries (2014-2019)

    5.2 USA Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    5.3 Canada Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    5.4 Mexico Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    6 Europe Acute Kidney Injury Treatment Revenue by Countries

    6.1 Europe Acute Kidney Injury Treatment Revenue by Countries (2014-2019)

    6.2 Germany Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    6.3 UK Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    6.4 France Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    6.5 Russia Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    6.6 Italy Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Acute Kidney Injury Treatment Revenue by Countries

    7.1 Asia-Pacific Acute Kidney Injury Treatment Revenue by Countries (2014-2019)

    7.2 China Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    7.3 Japan Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    7.4 Korea Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    7.5 India Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    7.6 Southeast Asia Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    8 South America Acute Kidney Injury Treatment Revenue by Countries

    8.1 South America Acute Kidney Injury Treatment Revenue by Countries (2014-2019)

    8.2 Brazil Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    8.3 Argentina Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    8.4 Colombia Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Acute Kidney Injury Treatment by Countries

    9.1 Middle East and Africa Acute Kidney Injury Treatment Revenue by Countries (2014-2019)

    9.2 Saudi Arabia Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    9.3 UAE Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    9.4 Egypt Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    9.5 Nigeria Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    9.6 South Africa Acute Kidney Injury Treatment Revenue and Growth Rate (2014-2019)

    10 Global Acute Kidney Injury Treatment Market Segment by Type

    10.1 Global Acute Kidney Injury Treatment Revenue and Market Share by Type (2014-2019)

    10.2 Global Acute Kidney Injury Treatment Market Forecast by Type (2019-2024)

    10.3 Prerenal Acute Kidney Injury Revenue Growth Rate (2014-2024)

    10.4 Postrenal Acute Kidney Injury Revenue Growth Rate (2014-2024)

    10.5 Intrinsic Renal Acute Kidney Injury Revenue Growth Rate (2014-2024)

    11 Global Acute Kidney Injury Treatment Market Segment by Application

    11.1 Global Acute Kidney Injury Treatment Revenue Market Share by Application (2014-2019)

    11.2 Acute Kidney Injury Treatment Market Forecast by Application (2019-2024)

    11.3 Hospitals Revenue Growth (2014-2019)

    11.4 Ambulatory Surgical Centers Revenue Growth (2014-2019)

    11.5 Others Revenue Growth (2014-2019)

    12 Global Acute Kidney Injury Treatment Market Size Forecast (2019-2024)

    12.1 Global Acute Kidney Injury Treatment Market Size Forecast (2019-2024)

    12.2 Global Acute Kidney Injury Treatment Market Forecast by Regions (2019-2024)

    12.3 North America Acute Kidney Injury Treatment Revenue Market Forecast (2019-2024)

    12.4 Europe Acute Kidney Injury Treatment Revenue Market Forecast (2019-2024)

    12.5 Asia-Pacific Acute Kidney Injury Treatment Revenue Market Forecast (2019-2024)

    12.6 South America Acute Kidney Injury Treatment Revenue Market Forecast (2019-2024)

    12.7 Middle East and Africa Acute Kidney Injury Treatment Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

    14 Appendix

    14.1 Methodology

    14.2 Data Source

     

This is a single user license, allowing one specific user access to the product.

This is a 1-10 user licence, allowing up to ten users have access to the product.

This is a site license, allowing all users within a given geographical location of your organisation access to the product.

The report will sent to you in PDF format via email.

Need Assistance ?